My Quote Request
6505-01-152-4626
20 Products
NDC00781-2080-01
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011524626
NSN
6505-01-152-4626
NDC00781-2080-01
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011524626
NSN
6505-01-152-4626
MFG
GENEVA PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
2D0790
WATER FOR INHALATION,STERILE,USP
NSN, MFG P/N
6505011518078
NSN
6505-01-151-8078
2D0790
WATER FOR INHALATION,STERILE,USP
NSN, MFG P/N
6505011518078
NSN
6505-01-151-8078
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ADMINISTRATION: NEBULIZATION
PRIMARY CONTAINER CONTENT QUANTITY: 150.000 MILLILITERS
PRIMARY CONTAINER TYPE: ULTRASONIC NEBULIZER CUP
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
NDC00006-3366-12
TIMOLOL MALEATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011519029
NSN
6505-01-151-9029
NDC00006-3366-12
TIMOLOL MALEATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011519029
NSN
6505-01-151-9029
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 0.250 PERCENT TIMOLOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
Related Searches:
TIMOPTIC
TIMOLOL MALEATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011519029
NSN
6505-01-151-9029
TIMOPTIC
TIMOLOL MALEATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011519029
NSN
6505-01-151-9029
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 0.250 PERCENT TIMOLOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
Related Searches:
NDC00006-3367-12
TIMOLOL MALEATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011519030
NSN
6505-01-151-9030
NDC00006-3367-12
TIMOLOL MALEATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011519030
NSN
6505-01-151-9030
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 0.500 PERCENT TIMOLOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
Related Searches:
TIMOPTIC
TIMOLOL MALEATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011519030
NSN
6505-01-151-9030
TIMOPTIC
TIMOLOL MALEATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011519030
NSN
6505-01-151-9030
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 0.500 PERCENT TIMOLOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
Related Searches:
NDC00071-0490-24
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011521983
NSN
6505-01-152-1983
NDC00071-0490-24
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011521983
NSN
6505-01-152-1983
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 975.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ASPIRIN DELAYED RELEASE TABLETS USP 0.975 GRAM 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00904-5212-60
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011521983
NSN
6505-01-152-1983
NDC00904-5212-60
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011521983
NSN
6505-01-152-1983
MFG
MAJOR PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 975.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ASPIRIN DELAYED RELEASE TABLETS USP 0.975 GRAM 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC59417-0975-71
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011521983
NSN
6505-01-152-1983
NDC59417-0975-71
ASPIRIN DELAYED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011521983
NSN
6505-01-152-1983
MFG
LOTUS BIOCHEMICAL CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 975.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ASPIRIN DELAYED RELEASE TABLETS USP 0.975 GRAM 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00005-4198-31
MULTIVITAMIN TABLETS
NSN, MFG P/N
6505011521984
NSN
6505-01-152-1984
NDC00005-4198-31
MULTIVITAMIN TABLETS
NSN, MFG P/N
6505011521984
NSN
6505-01-152-1984
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 45.000 MICROGRAMS BIOTIN ACTIVE INGREDIENT AND 20.000 MILLIGRAMS CALCIUM PANTOTHENATE ACTIVE INGREDIENT AND 400.000 MICROGRAMS FOLIC ACID ACTIVE INGREDIENT AND 100.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 15.000 MILLIGRAMS RIBOFLAVIN ACTIVE
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:FILM,NONENTERIC;
~1: INGREDIENT AND 15.000 MILLIGRAMS THIAMINE ACTIVE INGREDIENT AND 5.000 MILLIGRAMS VITAMIN B6 ACTIVE INGREDIENT AND 12.000 MICROGRAMS VITAMIN B12 ACTIVE INGREDIENT AND 600.000 MILLIGRAMS VITAMIN C ACTIVE INGREDIENT AND 30.000 USP UNITS VITAMIN E ACTIVE
~2: INGREDIENT
Related Searches:
STRESSTABS 600
MULTIVITAMIN TABLETS
NSN, MFG P/N
6505011521984
NSN
6505-01-152-1984
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 45.000 MICROGRAMS BIOTIN ACTIVE INGREDIENT AND 20.000 MILLIGRAMS CALCIUM PANTOTHENATE ACTIVE INGREDIENT AND 400.000 MICROGRAMS FOLIC ACID ACTIVE INGREDIENT AND 100.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 15.000 MILLIGRAMS RIBOFLAVIN ACTIVE
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:FILM,NONENTERIC;
~1: INGREDIENT AND 15.000 MILLIGRAMS THIAMINE ACTIVE INGREDIENT AND 5.000 MILLIGRAMS VITAMIN B6 ACTIVE INGREDIENT AND 12.000 MICROGRAMS VITAMIN B12 ACTIVE INGREDIENT AND 600.000 MILLIGRAMS VITAMIN C ACTIVE INGREDIENT AND 30.000 USP UNITS VITAMIN E ACTIVE
~2: INGREDIENT
Related Searches:
CECLOR
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011523607
NSN
6505-01-152-3607
CECLOR
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011523607
NSN
6505-01-152-3607
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 GRAMS CEFACLOR ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFACLOR FOR ORAL SUSPENSION SUP 75ML BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO PROVIDE 250 MG OF CEFACLOR PER 5 ML WHEN RECONSTITUTED TO 75 ML
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE WITH CHILD-RESISTANT SAFETY CLOSURE OF SUFFICIENT CAPACITY TO HOLD 75 ML WITH ADEQUATE SHAKE SPACE
Related Searches:
NDC00002-5058-18
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011523607
NSN
6505-01-152-3607
NDC00002-5058-18
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011523607
NSN
6505-01-152-3607
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 GRAMS CEFACLOR ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFACLOR FOR ORAL SUSPENSION SUP 75ML BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO PROVIDE 250 MG OF CEFACLOR PER 5 ML WHEN RECONSTITUTED TO 75 ML
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE WITH CHILD-RESISTANT SAFETY CLOSURE OF SUFFICIENT CAPACITY TO HOLD 75 ML WITH ADEQUATE SHAKE SPACE
Related Searches:
NDC00378-7610-12
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011523607
NSN
6505-01-152-3607
NDC00378-7610-12
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011523607
NSN
6505-01-152-3607
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 GRAMS CEFACLOR ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFACLOR FOR ORAL SUSPENSION SUP 75ML BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO PROVIDE 250 MG OF CEFACLOR PER 5 ML WHEN RECONSTITUTED TO 75 ML
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE WITH CHILD-RESISTANT SAFETY CLOSURE OF SUFFICIENT CAPACITY TO HOLD 75 ML WITH ADEQUATE SHAKE SPACE
Related Searches:
NDC59772-7492-20
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011523607
NSN
6505-01-152-3607
NDC59772-7492-20
CEFACLOR FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505011523607
NSN
6505-01-152-3607
MFG
BRISTOL-MYERS CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 GRAMS CEFACLOR ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFACLOR FOR ORAL SUSPENSION SUP 75ML BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO PROVIDE 250 MG OF CEFACLOR PER 5 ML WHEN RECONSTITUTED TO 75 ML
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE WITH CHILD-RESISTANT SAFETY CLOSURE OF SUFFICIENT CAPACITY TO HOLD 75 ML WITH ADEQUATE SHAKE SPACE
Related Searches:
NDC00916-0805-25
DOCUSATE SODIUM SOLUTION,MODIFIED
NSN, MFG P/N
6505011524180
NSN
6505-01-152-4180
NDC00916-0805-25
DOCUSATE SODIUM SOLUTION,MODIFIED
NSN, MFG P/N
6505011524180
NSN
6505-01-152-4180
MFG
CHAMBERLIN CORP THE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS DOCUSATE SODIUM PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 MILLILITERS
PRIMARY CONTAINER TYPE: CUP,PATIENT
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
METRO IV
METRONIDAZOLE INJECTION,USP
NSN, MFG P/N
6505011524181
NSN
6505-01-152-4181
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METRONIDAZOLE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITH VENTED STOPPER AND HANGER
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00264-1939-33
METRONIDAZOLE INJECTION,USP
NSN, MFG P/N
6505011524181
NSN
6505-01-152-4181
NDC00264-1939-33
METRONIDAZOLE INJECTION,USP
NSN, MFG P/N
6505011524181
NSN
6505-01-152-4181
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METRONIDAZOLE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITH VENTED STOPPER AND HANGER
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
S9384-52
METRONIDAZOLE INJECTION,USP
NSN, MFG P/N
6505011524181
NSN
6505-01-152-4181
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METRONIDAZOLE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITH VENTED STOPPER AND HANGER
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00005-3748-62
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011524626
NSN
6505-01-152-4626
NDC00005-3748-62
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505011524626
NSN
6505-01-152-4626
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE